Zum Inhalt springen
Home » Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended December 31, 2023.

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates